Revenue
2017
2018
2019
2020
2021
2022
2023
2024
2025
Bionano Genomics, Inc. (BNGO)
Price$1.53Cached quote
Net income
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $28.5M | $30.8M | $36.1M | $27.8M | $18.0M | $8.5M | $10.1M | $12.0M | $9.5M |
| Gross profit | $13.2M | $380,000 | $9.6M | $5.9M | $3.9M | $2.8M | $3.4M | $3.3M | $3.5M |
| Gross margin | 46.25% | 1.23% | 26.49% | 21.38% | 21.54% | 32.61% | 33.18% | 27.41% | 36.55% |
| Research & development | $11.4M | $24.8M | $54.0M | $49.0M | $22.5M | $10.3M | $9.1M | $9.5M | $12.0M |
| Operating expenses | $46.5M | $104.4M | $224.8M | $137.6M | $81.0M | $41.3M | $29.2M | $23.7M | $26.7M |
| Operating income | −$33.3M | −$104.0M | −$215.2M | −$131.7M | −$77.1M | −$38.6M | −$25.9M | −$20.4M | −$23.2M |
| Operating margin | −116.95% | −337.87% | −595.98% | −473.70% | −428.79% | −453.38% | −255.44% | −170.12% | −244.28% |
| EBITDA | −$23.8M | −$90.0M | −$201.5M | −$122.1M | −$73.8M | −$37.1M | −$24.7M | −$19.1M | −$21.7M |
| EBITDA margin | −83.53% | −292.31% | −558.03% | −439.09% | −410.16% | −435.99% | −244.31% | −159.11% | −228.46% |
| Net income | −$26.4M | −$112.0M | −$232.5M | −$132.6M | −$72.4M | −$41.1M | −$29.8M | −$18.5M | −$23.4M |
| Net profit margin | −92.59% | −363.98% | −643.74% | −476.93% | −402.84% | −483.43% | −294.34% | −154.13% | −245.82% |
| Basic EPSper basic share | -$4.85 | -$88.13 | -$408.60 | -$16,422.25 | -$9,322.67 | -$13,984.01 | -$71,354.30 | -$93,585.28 | -$310,158.13 |
| Diluted EPSper diluted share | -$4.85 | -$88.13 | -$408.60 | -$16,422.25 | -$9,322.67 | -$13,984.01 | -$71,354.30 | -$93,585.28 | -$310,158.13 |
Owners
Reported shareholders
1.28%of listed shares
GSA CAPITAL PARTNERS LLP150.28K shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
GSA CAPITAL PARTNERS LLP | 1.28%150.28K shares |
CARRET ASSET MANAGEMENT, LLC | 1.06%125K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.76%89.99K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 0.70%82.39K shares |
VANGUARD FIDUCIARY TRUST CO | 0.44%51.58K shares |
RENAISSANCE TECHNOLOGIES LLC | 0.43%51.1K shares |
JANE STREET GROUP, LLC | 0.30%35.73K shares |
PRUDENTIAL FINANCIAL INC | 0.27%31.6K shares |
NORTHERN TRUST CORP | 0.21%24.56K shares |
XTX Topco Ltd | 0.14%16.3K shares |
Engineers Gate Manager LP | 0.10%11.99K shares |
HRT FINANCIAL LP | 0.10%11.74K shares |
BlackRock, Inc. | 0.08%9.94K shares |
OSAIC HOLDINGS, INC. | 0.07%7.81K shares |
Tower Research Capital LLC (TRC) | 0.04%5.23K shares |
Holmlin R. Erik | ≈0.01%1.66K shares |
MORGAN STANLEY | <0.01%1.04K shares |
Concord Wealth Partners | <0.01%1K shares |
GROUP ONE TRADING LLC | <0.01%957 shares |
OLDAKOWSKI MARK | ≈<0.01%868 shares |
Percentages use 11.78M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data